Publication | Closed Access

Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS)

Hormonal ContraceptiveOral ContraceptiveReproductive HealthGynecologyPolycystic Ovary SyndromeMenstrual CycleEndocrinologyMedicineAsymmetric DimethylarginineOvarian HormoneWomen's HealthOral Contraceptive Treatments